Clinical Trials Directory

Trials / Completed

CompletedNCT00898391

Study of DNA in Blood Samples From Patients With Neuroblastoma

Analysis of Circulating MYCN DNA in Serum Samples Obtained From Patients With Neuroblastoma

Status
Completed
Phase
Study type
Observational
Enrollment
329 (actual)
Sponsor
Children's Oncology Group · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This research trial studies is deoxyribonucleic acid (DNA) in blood samples from patients with neuroblastoma. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

Detailed description

OBJECTIVES: I. Perform in a blind study a multicentric study by analyzing serum from patients at diagnosis (with a known tumor v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) status determined in the Children's Oncology Group \[COG\] reference lab), in order to confirm our previous data and to define the most appropriate MYCN/control ratio cutoff capable of determining positive and negative cases. II. Define the limits of the procedure in non-metastatic patients and in those with reduced tumor burden (International Neuroblastoma Staging System \[INSS\] stage 1 and 2). OUTLINE: Circulating DNA is extracted from serum. Polymerase chain reaction (PCR) amplification of MYCN is performed and analyzed by agarose gel electrophoresis. Real-time quantitative PCR is also performed.

Conditions

Interventions

TypeNameDescription
OTHERlaboratory biomarker analysisCorrelative studies
GENETICpolymerase chain reactionCorrelative studies
GENETICpolyacrylamide gel electrophoresisCorrelative studies
GENETICDNA analysisCorrelative studies

Timeline

Start date
2007-06-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2009-05-12
Last updated
2016-05-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00898391. Inclusion in this directory is not an endorsement.